Boule Diagnostics AB (publ) (STO:BOUL)

Market Cap	201.93M -47.8%
Revenue (ttm)	512.66M -9.0%
Net Income	-80.98M
EPS	-2.10
Shares Out	38.83M
PE Ratio	n/a
Forward PE	7.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,464
Average Volume	20,603
Open	5.22
Previous Close	5.20
Day's Range	4.98 - 5.24
52-Week Range	4.60 - 10.60
Beta	0.24
RSI	44.87
Earnings Date	Feb 11, 2026

About Boule Diagnostics AB

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and vet...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1956
• Employees: 200
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BOUL